GlassScriptPhysician profile
Timothy G Cundiff
NPI 1912169962
$8,314.33
in general payments reported to CMS, 2019-2025
16 companies · $255 in 2025
The $255 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,860 · 2020: $424 · 2021: $272 · 2022: $452 · 2023: $499 · 2024: $551 · 2025: $255.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,248 · Entertainment: $57.39.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,248.01 |
| Entertainment | $57.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optos, INC. | $3,510.66 | 2019-2025 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $2,087.28 | 2019-2021 | |
| Alcon Vision LLC | $566.95 | 2019-2025 | Total30, Precision7 |
| Optos Plc | $434.26 | 2019 | |
| Bausch & Lomb Americas INC. | $391.30 | 2022-2024 | Infuse, Miebo, Biotrue |
| Coopervision INC. | $244.88 | 2020-2025 | Clariti Contact Lens, Myday Contact Lens |
| Allergan, INC. | $199.01 | 2021-2022 | |
| Sun Pharmaceutical Industries INC. | $167.66 | 2023-2025 | Cequa |
| Tarsus Pharmaceuticals, INC. | $161.97 | 2024-2025 | Xdemvy |
| Johnson & Johnson Vision Care, INC. | $151.35 | 2019-2024 | |
| Glaukos Corporation | $116.01 | 2019 | |
| Biotissue Holdings INC. | $98.87 | 2022 | |
| Oyster Point Pharma, INC. | $73.74 | 2023 | Tyrvaya |
| Dompe US, INC. | $59.38 | 2023 | Oxervate |
| Carl Zeiss Meditec Ag | $38.80 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abb Con-Cise Optical Group LLC | $12.21 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Cundiff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.